Clinical Trial Update: Trial to Evaluate Safety and Tolerability of ALN-PCS02 in Subjects With Elevated LDL-Cholesterol (LDL-C) [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety and tolerability of ALN-PCS02 in adults with elevated LDL-cholesterol has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Hyperlipidemia

Drugs mentioned

• ALN-PCS02

Snippet

Sponsor: Alnylam Pharmaceuticals | Conditions: Elevated LDL-Cholesterol (LDL-C) | Phase 1 | Status: COMPLETED